Akebia Therapeutics, Inc. (AKBA)
0.9001
-0.01
(-0.72%)
USD |
NASDAQ |
Aug 24, 16:00
0.9001
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price : 0.9001 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 0.9249 | 0.955 | 0.9054 | 0.9066 | 6.450M |
| Aug 20, 2026 | 0.88 | 0.9298 | 0.8722 | 0.9194 | 13.72M |
| Aug 19, 2026 | 0.8518 | 0.8977 | 0.85 | 0.8854 | 9.876M |
| Aug 18, 2026 | 0.8569 | 0.8626 | 0.8382 | 0.8518 | 1.955M |
| Aug 17, 2026 | 0.87 | 0.88 | 0.814 | 0.86 | 4.264M |
| Aug 14, 2026 | 0.87 | 0.8882 | 0.8581 | 0.8728 | 2.087M |
| Aug 13, 2026 | 0.9046 | 0.949 | 0.8641 | 0.8696 | 4.093M |
| Aug 12, 2026 | 0.8724 | 0.91 | 0.867 | 0.8932 | 4.555M |
| Aug 11, 2026 | 0.84 | 0.8849 | 0.84 | 0.8665 | 3.794M |
| Aug 10, 2026 | 0.90 | 0.909 | 0.8367 | 0.844 | 8.490M |
| Aug 07, 2026 | 0.961 | 0.962 | 0.8862 | 0.9099 | 10.93M |
| Aug 06, 2026 | 0.9021 | 1.01 | 0.85 | 0.9544 | 17.69M |
| Aug 05, 2026 | 1.32 | 1.355 | 1.28 | 1.29 | 4.528M |
| Aug 04, 2026 | 1.31 | 1.35 | 1.31 | 1.32 | 2.696M |
| Aug 03, 2026 | 1.31 | 1.34 | 1.295 | 1.31 | 2.096M |
| Jul 31, 2026 | 1.34 | 1.349 | 1.295 | 1.32 | 2.058M |
| Jul 30, 2026 | 1.24 | 1.36 | 1.24 | 1.35 | 3.117M |
| Jul 29, 2026 | 1.26 | 1.28 | 1.24 | 1.26 | 1.962M |
| Jul 28, 2026 | 1.28 | 1.29 | 1.22 | 1.27 | 1.667M |
| Jul 27, 2026 | 1.24 | 1.30 | 1.24 | 1.28 | 1.859M |
| Jul 24, 2026 | 1.22 | 1.235 | 1.20 | 1.22 | 1.496M |
| Jul 23, 2026 | 1.23 | 1.25 | 1.19 | 1.22 | 1.627M |
| Jul 22, 2026 | 1.31 | 1.31 | 1.25 | 1.26 | 2.160M |
| Jul 21, 2026 | 1.27 | 1.33 | 1.27 | 1.30 | 1.776M |
| Jul 20, 2026 | 1.33 | 1.38 | 1.26 | 1.28 | 2.941M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Emergent BioSolutions, Inc. | 5.17 |
| Exelixis, Inc. | 54.57 |
| ADMA Biologics, Inc. | 9.545 |
| Arcutis Biotherapeutics, Inc. | 24.79 |
| Relay Therapeutics, Inc. | 19.76 |
Price Related Metrics
| PS Ratio | 1.106 |
| Price to Book Value | 9.776 |
| Price to Free Cash Flow | 6.016 |
| Earnings Yield | -12.33% |
| Market Cap | 244.60M |